[HTML][HTML] Drug and cell delivery for cardiac regeneration

CL Hastings, ET Roche, E Ruiz-Hernandez… - Advanced drug delivery …, 2015 - Elsevier
The spectrum of ischaemic cardiomyopathy, encompassing acute myocardial infarction to
congestive heart failure is a significant clinical issue in the modern era. This group of …

The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge

G Cavallaro, L Filippi, P Bagnoli… - Acta …, 2014 - Wiley Online Library
Retinopathy of prematurity (ROP) is a disease that can cause blindness in very low
birthweight infants. The incidence of ROP is closely correlated with the weight and the …

[HTML][HTML] A proliferative burst during preadolescence establishes the final cardiomyocyte number

N Naqvi, M Li, JW Calvert, T Tejada, JP Lambert, J Wu… - Cell, 2014 - cell.com
It is widely believed that perinatal cardiomyocyte terminal differentiation blocks cytokinesis,
thereby causing binucleation and limiting regenerative repair after injury. This suggests that …

Telomere biology in healthy aging and disease

H Oeseburg, RA de Boer, WH Van Gilst… - … -European Journal of …, 2010 - Springer
Aging is a biological process that affects most cells, organisms and species. Telomeres have
been postulated as a universal biological clock that shortens in parallel with aging in cells …

Anemia and chronic heart failure: implications and treatment options

IS Anand - Journal of the American College of Cardiology, 2008 - jacc.org
Anemia is a common comorbidity in patients with heart failure and is associated with worse
long-term outcomes. Although the cause of anemia in heart failure is unclear, the weight of …

The non‐haematopoietic biological effects of erythropoietin

MO Arcasoy - British journal of haematology, 2008 - Wiley Online Library
In the haematopoietic system, the principal function of erythropoietin (Epo) is the regulation
of red blood cell production, mediated by its specific cell surface receptor (EpoR). Following …

Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches

DJ Van Veldhuisen, SD Anker, P Ponikowski… - Nature Reviews …, 2011 - nature.com
Anemia and iron deficiency are common in patients with heart failure (HF), and are
associated with worse symptoms and adverse outcomes in this population. Although the two …

Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure

M Yin, ICC van der Horst… - American Journal …, 2011 - journals.physiology.org
Metformin is the first choice drug for the treatment of patients with diabetes, but its use is
debated in patients with advanced cardiorenal disease. Epidemiological data suggest that …

Erythropoietin and its angiogenic activity

P Kimáková, P Solár, Z Solárová, R Komel… - International journal of …, 2017 - mdpi.com
Erythropoietin (EPO) is the main hematopoietic hormone acting on progenitor red blood
cells via stimulation of cell growth, differentiation, and anti-apoptosis. However, its receptor …

Exercise training and peripheral arterial disease

TL Haas, PG Lloyd, HT Yang… - Comprehensive …, 2012 - Wiley Online Library
Peripheral arterial disease (PAD) is a common vascular disease that reduces blood flow
capacity to the legs of patients. PAD leads to exercise intolerance that can progress in …